Novartis has started to feel the squeeze from generics to its top-selling drug, heart therapy Entresto. | Novartis has ...
AbbVie Inc. is reiterated as a Strong Buy ahead of Q3 earnings, with revenue growth expected to outpace the sector median.
More than half of adolescents treated with baricitinib achieved complete or near-complete scalp hair regrowth at 1 year, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback